TG3 is a monoclonal antibody that labels tau neuropathology in AD cases [72] that is specific for phosphorylation at Thr231 and was shown to have enhanced signal when halogenated alcohol, trifluoroethanol, was used instead of water during peptide coating [71]. This evidence concerns the gene MAPT and Alzheimer disease.